These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
¨
|
Preliminary Proxy Statement
|
|
|
|
|
|
|
¨
|
Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
|
|
|
|
|
|
þ
|
Definitive Proxy Statement
|
|
|
|
|
|
|
¨
|
Definitive Additional Materials
|
|
|
|
|
|
|
¨
|
Soliciting Material Pursuant to 240.14a-12
|
|
|
|
||
|
iRobot Corporation
|
||
|
(Name of Registrant as Specified in Its Charter)
|
||
|
|
||
|
|
||
|
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
|
||
|
|
||
|
Payment of Filing Fee (Check the appropriate box):
|
||
|
|
|
|
|
þ
|
No fee required.
|
|
|
|
|
|
|
¨
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
|
|
|
|
|
|
|
1)
|
Title of each class of securities to which transaction applies:
|
|
|
|
|
|
|
2)
|
Aggregate number of securities to which transaction applies:
|
|
|
|
|
|
|
3)
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
|
|
|
|
|
|
|
4)
|
Proposed maximum aggregate value of transaction:
|
|
|
|
|
|
|
5)
|
Total fee paid:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
¨
|
Fee paid previously with preliminary materials.
|
|
|
|
|
|
|
¨
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
|
|
|
|
|
|
|
|
1)
|
Amount previously paid:
|
|
|
|
|
|
|
2)
|
Form, Schedule or Registration Statement No.:
|
|
|
|
|
|
|
3)
|
Filing Party:
|
|
|
|
|
|
|
4)
|
Date Filed:
|
|
|
|
|
|
|
|
|
Dear Stockholder:
|
April 13, 2015
|
|
|
2014
|
|
2015
|
|
Corporate Governance
|
Termination of rights plan - "poison pill"
|
|
Adoption of majority voting standards for removal of directors and amendments to certain provisions of our certificate of incorporation
|
|
|
Adopted majority voting standard for election of directors
|
|
|
|
|
|
|
|
|
Executive Compensation
|
Designed 50% of executives' LTI to be based on the Company's financial performance
|
|
Inclusion of clawback policy
|
|
Annual "say-on-pay" vote
|
|
No pension benefits for executive officers
|
|
Clawback policy
|
|
No discounted options
|
|
Strong stock ownership and stock holding guidelines
|
|
No option repricing without stockholder approval
|
|
Oversight of risks associated with compensation policies and practice
|
|
No excise tax gross-ups
|
|
"Double trigger" change in control agreements
|
|
No hedging or pledging of Company stock
|
|
Independent compensation consultant
|
|
No excessive perquisites for executives
|
|
|
|
|
PROXY STATEMENT
|
|
|
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
|
|
|
PROPOSAL 1 — ELECTION OF DIRECTORS
|
|
|
Nominees
|
|
|
Recommendation of the Board
|
|
|
DIRECTORS AND EXECUTIVE OFFICERS
|
|
|
CORPORATE GOVERNANCE AND BOARD MATTERS
|
|
|
Board Leadership Structure
|
|
|
Independence of Members of the Board of Directors
|
|
|
Executive Sessions of Independent Directors
|
|
|
The Board of Directors’ Role in Risk Oversight
|
|
|
Policies Governing Director Nominations
|
|
|
Policy Governing Security Holder Communications with the Board of Directors
|
|
|
Policy Governing Director Attendance at Annual Meetings of Stockholders
|
|
|
Board of Directors Evaluation Program
|
|
|
Code of Ethics
|
|
|
THE BOARD OF DIRECTORS AND ITS COMMITTEES
|
|
|
Board of Directors
|
|
|
Audit Committee
|
|
|
Compensation Committee
|
|
|
Nominating and Corporate Governance Committee
|
|
|
Compensation Committee Interlocks and Insider Participation
|
|
|
REPORT OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS
|
|
|
REPORT OF THE COMPENSATION COMMITTEE OF THE BOARD OF DIRECTORS
|
|
|
COMPENSATION AND OTHER INFORMATION CONCERNING EXECUTIVE OFFICERS AND DIRECTORS
|
|
|
Compensation Discussion & Analysis
|
|
|
Executive Compensation Summary
|
|
|
Grants of Plan-Based Awards in 2014
|
|
|
Outstanding Equity Awards at Fiscal Year End
|
|
|
Options Exercises and Stock Vested
|
|
|
Potential Benefits Upon Termination or Change in Control
|
|
|
Director Compensation
|
|
|
Transactions with Related Persons
|
|
|
PROPOSAL 2 — RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTANTS
|
|
|
PricewaterhouseCoopers LLP Fees
|
|
|
Recommendation of the Board
|
|
|
PROPOSAL 3 — APPROVAL OF THE IROBOT CORPORATION 2015 STOCK OPTION AND INCENTIVE PLAN
|
|
|
Recommendation of the Board
|
|
|
PROPOSAL 4 - APPROVAL OF THE AMENDMENTS TO OUR AMENDED AND RESTATED CERTIFICATE OF INCORPORATION TO ADOPT MAJORITY VOTING STANDARDS
|
|
|
Recommendation of the Board
|
|
|
PROPOSAL 5 - ADVISORY VOTE ON THE APPROVAL OF THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS
|
|
|
Recommendation of the Board
|
|
|
PROPOSAL 6 - STOCKHOLDER PROPOSAL ENTITLED "ELECT EACH DIRECTOR ANNUALLY"
|
|
|
Recommendation of the Board
|
|
|
OTHER MATTERS
|
|
|
Name of Beneficial Owner
|
|
Shares Beneficially
Owned(1) |
|
Percentage of Shares
Beneficially Owned(2) |
|
BlackRock, Inc.(3)
40 East 52
nd
St.
New York, NY 10022
|
|
2,512,817
|
|
8.50%
|
|
The Vanguard Group, Inc.(4)
100 Vanguard Boulevard
Malvern, PA 19355
|
|
1,841,733
|
|
6.23%
|
|
T. Rowe Price Associates, Inc.(5)
100 East Pratt Street
Baltimore, MD 21202-1009
|
|
1,669,000
|
|
5.60%
|
|
Colin M. Angle(6)
|
|
694,474
|
|
2.34%
|
|
Alison Dean(7)
|
|
53,868
|
|
*
|
|
Russell J. Campanello(8)
|
|
89,374
|
|
*
|
|
Paolo Pirjanian (9)
|
|
75,146
|
|
*
|
|
Glen D. Weinstein(10)
|
|
60,303
|
|
*
|
|
Christian Cerda (11)
|
|
49,087
|
|
*
|
|
Ronald Chwang(12)
|
|
260,806
|
|
*
|
|
Gail Deegan(13)
|
|
11,596
|
|
*
|
|
Deborah G. Ellinger(14)
|
|
15,424
|
|
*
|
|
Andrea Geisser(15)
|
|
72,145
|
|
*
|
|
George C. McNamee(16)
|
|
156,282
|
|
*
|
|
Paul J. Kern(17)
|
|
83,147
|
|
*
|
|
Paul Sagan(18)
|
|
21,922
|
|
*
|
|
Michelle V. Stacy
|
|
—
|
|
*
|
|
All executive officers, directors and nominees as a group(19) (14 persons)
|
|
1,643,574
|
|
5.53%
|
|
*
|
Represents less than 1% of the outstanding common stock.
|
|
(1)
|
Beneficial ownership is determined in accordance with the rules of the Securities and Exchange Commission and includes voting and investment power with respect to shares. Unless otherwise indicated below, to the knowledge of the Company, all persons listed below have sole voting and investment power with respect to their shares of common stock, except to the extent authority is shared by spouses under applicable law. Pursuant to the rules of the Securities and Exchange Commission, the number of shares of common stock deemed outstanding includes (i) shares issuable pursuant to options held by the respective person or group that are currently exercisable or may be exercised within 60 days of March 27, 2015 and (ii) shares issuable pursuant to restricted stock units held by the respective person or group that vest within 60 days of March 27, 2015.
|
|
(2)
|
Applicable percentage of ownership as of March 27, 2015 is based upon 29,707,029 shares of common stock outstanding.
|
|
(3)
|
BlackRock Inc. has sole voting power with respect to 2,448,066 shares and sole dispositive power with respect to 2,512,817 shares. This information has been obtained from a Schedule 13G/A filed by BlackRock Inc. with the Securities and Exchange Commission on January 22, 2015.
|
|
(4)
|
The Vanguard Group Inc. has sole voting power with respect to 41,709 shares, sole dispositive power with respect to 1,802,924 shares and shared dispositive power with respect to 38,809 shares. Vanguard Fiduciary Trust Company ("VFTC"), a wholly-owned subsidiary of The Vanguard Group, Inc., is the beneficial owner of 38,809 shares as a result of its serving as investment manager of collective trust accounts. Vanguard Investments Australia, Ltd. ("VIA"), a wholly-owned subsidiary of The Vanguard Group, Inc., is the beneficial owner of 2,900 shares as a result of its serving as investment manager of
|
|
(5)
|
T. Rowe Price Associates, Inc. has sole voting power with respect to 391,600 shares and sole dispositive power with respect to 1,669,000 shares. This information has been obtained from a Schedule 13G filed by T. Rowe Price Associates, Inc. with the Securities and Exchange Commission on February 13, 2015. The address of T. Rowe Price Associates, Inc. is 100 E. Pratt Street, Baltimore, MD 21202.
|
|
(6)
|
Includes 290,480 shares issuable to Mr. Angle upon exercise of stock options and 5,700 shares issuable to Mr. Angle upon vesting of restricted stock units.
|
|
(7)
|
Includes 32,888 shares issuable to Ms. Dean upon exercise of stock options and 931 shares issuable to Ms. Dean upon vesting of restricted stock units.
|
|
(8)
|
Includes 50,152 shares issuable to Mr. Campanello upon exercise of stock options.
|
|
(9)
|
Includes 65,059 shares issuable to Dr. Pirjanian upon exercise of stock options.
|
|
(10)
|
Includes 22,035 shares issuable to Mr. Weinstein upon exercise of stock options and 1,437 shares issuable to Mr. Weinstein upon vesting of restricted stock units.
|
|
(11)
|
Includes 31,798 shares issuable to Mr. Cerda upon exercise of stock options.
|
|
(12)
|
Includes an aggregate of 140,000 shares held by iD5 Fund, L.P. Dr. Chwang is a general partner of the management company for iD5 Fund, L.P. and may be deemed to share voting and investment power with respect to all shares held by iD5 Fund, L.P. Dr. Chwang disclaims beneficial ownership of such shares except to the extent of his pecuniary interest, if any. Also includes 30,000 shares issuable to Dr. Chwang upon exercise of stock options, 3,243 shares issuable to Dr. Chwang upon vesting of restricted stock options and 79,210 shares held in a trust for the benefit of certain of his family members. As co-trustees of the family trust, Dr. Chwang shares voting and dispositive power over the shares held by the trust with his spouse.
|
|
(13)
|
Includes 3,243 shares issuable to Ms. Deegan upon vesting of restricted stock units.
|
|
(14)
|
Includes 3,243 shares issuable to Ms. Ellinger upon vesting of restricted stock units.
|
|
(15)
|
Includes 40,000 shares issuable to Mr. Geisser upon exercise of stock options, 3,243 shares issuable to Mr. Geisser upon vesting of restricted stock units and 12,643 shares issuable to Mr. Geisser upon termination of service.
|
|
(16)
|
Includes 70,000 shares issuable to Mr. McNamee upon exercise of stock options, 3,243 shares issuable to Mr. McNamee upon vesting of restricted stock units and 3,487 shares issuable to Mr. McNamee upon termination of service.
|
|
(17)
|
Includes 60,000 shares issuable to Gen. Kern upon exercise of stock options, 3,243 shares issuable to Gen. Kern upon vesting of restricted stock units and 8,492 shares issuable to Gen. Kern upon termination of service.
|
|
(18)
|
Includes 2,500 shares issuable to Mr. Sagan upon exercise of stock options, 3,243 shares issuable to Mr. Sagan upon vesting of restricted stock units and 4,767 shares issuable to Mr. Sagan upon termination of service.
|
|
(19)
|
Includes an aggregate of 694,912 shares issuable upon exercise of stock options held by eleven executive officers and directors, an aggregate of 30,769 shares issuable upon vesting of restricted stock units held by ten executive officers and directors and an aggregate of 29,389 shares issuable upon termination of service to four (4) directors.
|
|
|
|
|
|
|
|
|
|
Nominee’s or Director’s Name and
Year First Became a Director
|
|
Position(s) with the Company
|
|
Year Current Term Will Expire
|
|
Current Class of Director
|
|
Nominees for Class I Directors:
|
|
|
|
|
|
|
|
Colin M. Angle
1992 |
|
Chairman of the Board, Chief Executive Officer and Director
|
|
2015
|
|
I
|
|
Ronald Chwang, Ph.D.
1998 |
|
Director
|
|
2015
|
|
I
|
|
Deborah G. Ellinger
2011 |
|
Director
|
|
2015
|
|
I
|
|
Nominee for Class III Directors:
|
|
|
|
|
|
|
|
Michelle V. Stacy
2014 (1) |
|
Director
|
|
2017
|
|
III
|
|
Continuing Directors:
|
|
|
|
|
|
|
|
George C. McNamee
1999
|
|
Director
|
|
2016
|
|
II
|
|
Paul Sagan
2010
|
|
Director
|
|
2016
|
|
II
|
|
Gail Deegan
2011
|
|
Director
|
|
2017
|
|
III
|
|
Andrea Geisser
2004
|
|
Director
|
|
2017
|
|
III
|
|
(1)
|
Ms. Stacy was appointed by the board of directors as a Class III director in August 2014. At the time of the appointment, the board of directors set Ms. Stacy's election by the stockholders to occur at the next scheduled annual meeting of stockholders.
|
|
|
|
|
|
|
|
Name
|
|
Age
|
|
Position
|
|
Colin M. Angle
|
|
47
|
|
Chairman of the Board, Chief Executive Officer and Director
|
|
Alison Dean
|
|
50
|
|
Executive Vice President, Chief Financial Officer, Treasurer and Principal Accounting Officer
|
|
Russell J. Campanello
|
|
59
|
|
Executive Vice President, Human Resources and Corporate Communications
|
|
Paolo Pirjanian, Ph.D.
|
|
47
|
|
Executive Vice President, Chief Technology Officer
|
|
Glen D. Weinstein
|
|
44
|
|
Executive Vice President, Chief Legal Officer
|
|
Christian Cerda
|
|
45
|
|
Senior Vice President and General Manager, Home Robots Business Unit
|
|
Ronald Chwang, Ph.D.(1)
|
|
67
|
|
Director
|
|
Gail Deegan(2)
|
|
68
|
|
Director
|
|
Deborah G. Ellinger(1)
|
|
56
|
|
Director
|
|
Andrea Geisser(2)
|
|
72
|
|
Director
|
|
George C. McNamee(1)(3)
|
|
68
|
|
Director
|
|
Paul J. Kern, Gen. U.S. Army (ret)(2)
|
|
69
|
|
Director
|
|
Paul Sagan(3)
|
|
56
|
|
Director
|
|
Michelle V. Stacy
|
|
60
|
|
Director
|
|
(1)
|
Member of compensation committee
|
|
(2)
|
Member of audit committee
|
|
(3)
|
Member of nominating and corporate governance committee
|
|
•
|
providing the chairman of the board with input as to preparation of agendas for meetings;
|
|
•
|
advising the chairman of the board as to the quality, quantity and timeliness of the flow of information from the Company’s management that is necessary for the independent directors to effectively and responsibly perform their duties;
|
|
•
|
coordinating and developing the agenda for the executive sessions of the independent directors;
|
|
•
|
acting as principal liaison between the independent directors and the chairman of the board on sensitive issues;
|
|
•
|
evaluating, along with the members of the compensation committee, the chief executive officer’s performance and meeting with the chief executive officer to discuss such evaluation; and
|
|
•
|
acting as chairperson of the board in the absence of the chairman of the board or a vacancy in the position of chairman of the board.
|
|
•
|
nominees must have experience at a strategic or policy making level in a business, government, non-profit or academic organization of high standing;
|
|
•
|
nominees must be highly accomplished in his or her respective field, with superior credentials and recognition;
|
|
•
|
nominees must be well regarded in the community and shall have a long-term reputation for the highest ethical and moral standards;
|
|
•
|
nominees must have sufficient time and availability to devote to the affairs of the Company, particularly in light of the number of boards on which the nominee may serve;
|
|
•
|
nominees must be free of conflicts of interest and potential conflicts of interest, in particular with relationships with other boards; and
|
|
•
|
nominees must, to the extent such nominee serves or has previously served on other boards, demonstrate a history of actively contributing at board meetings.
|
|
•
|
Name and address of the stockholder making the recommendation, as they appear on our books and records, and of such record holder’s beneficial owner;
|
|
•
|
Number of shares of our capital stock that are owned beneficially and held of record by such stockholder and such beneficial owner;
|
|
•
|
Name, age, business and residential address, educational background, current principal occupation or employment, and principal occupation or employment for the preceding five full fiscal years of the individual recommended for consideration as a director nominee;
|
|
•
|
All other information relating to the recommended candidate that would be required to be disclosed in solicitations of proxies for the election of directors or is otherwise required, in each case pursuant to Regulation 14A under the Exchange Act, including the recommended candidate’s written consent to being named in the proxy statement as a nominee and to serving as a director if approved by the board of directors and elected; and
|
|
•
|
A written statement from the stockholder making the recommendation stating why such recommended candidate meets our criteria and would be able to fulfill the duties of a director.
|
|
•
|
appointing, approving the compensation of, and assessing the independence of our independent registered public accounting firm;
|
|
•
|
pre-approving auditing and permissible non-audit services, and the terms of such services, to be provided by our independent registered public accounting firm;
|
|
•
|
reviewing and discussing with management and the independent registered public accounting firm our annual and quarterly financial statements and related disclosures;
|
|
•
|
coordinating the oversight and reviewing the adequacy of our internal control over financial reporting;
|
|
•
|
overseeing the performance of our internal auditors and internal audit functions, including reviewing the annual internal audit risk assessment as well as the scope of, and overall plans for, the annual internal audit program;
|
|
•
|
establishing policies and procedures for the receipt and retention of accounting related complaints and concerns;
|
|
•
|
reviewing and discussing with management risk assessment and risk management, including cyber security;
|
|
•
|
overseeing the development of business continuity plans;
|
|
•
|
overseeing our compliance with certain legal and regulatory requirements including, but not limited to, the Foreign Corrupt Practices Act;
|
|
•
|
preparing the audit committee report required by SEC rules to be included in our annual proxy statement: and
|
|
•
|
such other matters as the committee deems appropriate.
|
|
•
|
annually reviewing and approving corporate goals and objectives relevant to compensation of our chief executive officer and other executive officers;
|
|
•
|
evaluating the performance of our chief executive officer in light of such corporate goals and objectives and determining the compensation of our chief executive officer and other executive officers;
|
|
•
|
overseeing and administering our compensation, welfare, benefit and pension plans and similar plans and determining the compensation of all executive officers; and
|
|
•
|
reviewing and making recommendations to the board of directors with respect to director compensation.
|
|
•
|
developing and recommending to the board criteria for board and committee membership;
|
|
•
|
establishing procedures for identifying and evaluating director candidates including nominees recommended by stockholders;
|
|
•
|
identifying individuals qualified to become board members;
|
|
•
|
recommending to the board the persons to be nominated for election as directors and to each of the board’s committees;
|
|
•
|
developing and recommending to the board a code of business conduct and ethics and a set of corporate governance guidelines; and
|
|
•
|
overseeing the evaluation of the board and management.
|
|
•
|
Provide competitive compensation that attracts, motivates and retains the best talent and the highest caliber executives to help us to achieve our strategic objectives;
|
|
•
|
Connect a significant portion of the total potential compensation paid to executives to our annual financial performance;
|
|
•
|
Align management's interest with the interests of stockholders through long-term equity incentives; and
|
|
•
|
Provide management with performance goals directly linked to our annual longer-term plan for growth and profit.
|
|
For
|
11,448,782
|
|
59.55
|
%
|
|
Against
|
7,646,078
|
|
39.77
|
%
|
|
Abstain
|
129,742
|
|
0.68
|
%
|
|
For
|
16,284,875
|
|
89.12
|
%
|
|
Against
|
1,831,432
|
|
10.02
|
%
|
|
Abstain
|
156,710
|
|
0.86
|
%
|
|
•
|
Companies with revenues within a similar range and generally similar market capitalization;
|
|
•
|
Companies within comparable industries that focus on high-tech products (e.g., information technology, consumer durables, consumer services, aerospace/defense, capital goods, electronics equipment, instruments and components, healthcare technology, computers and peripherals, networking equipment and computer hardware);
|
|
•
|
Companies with highly-engineered products and complex technologies with multiple industry applications;
|
|
•
|
Technology companies whose products contain both hardware and software components; and
|
|
•
|
Companies with moderate to high sales growth and opportunity.
|
|
•
|
Other secondary criteria also considered include:
|
|
•
|
Companies classified as “disruptive innovation;”
|
|
•
|
Companies with products with brand recognition and/or disposable income “luxury” goods; and
|
|
•
|
Companies with moderate margins and levels of research and development expense.
|
|
3D Systems Corp.
|
Mercury Systems, Inc.
|
|
Accuray Incorporated
|
Netgear, Inc.
|
|
AeroVironment, Inc.
|
Orbital Sciences Corporation
|
|
American Science and Engineering, Inc.
|
Plantronics, Inc.
|
|
Bruker Corporation
|
Synaptics Incorporated
|
|
Cognex Corporation
|
Tivo, Inc.
|
|
Logitech International SA
|
Trimble Navigation Ltd..
|
|
Maxwell Technologies Inc.
|
Universal Electronics, Inc.
|
|
•
|
the scope and strategic impact of the executive officer's responsibilities,
|
|
•
|
our past business and segment performance, and future expectations,
|
|
•
|
our long-term goals and strategies,
|
|
•
|
the performance and experience of each individual,
|
|
•
|
past compensation levels of each individual and of the named executive officers as a group,
|
|
•
|
relative levels of pay among the executive officers,
|
|
•
|
the amount of each component of compensation in the context of the executive officer's total compensation and other benefits,
|
|
•
|
for each named executive officer, other than the chief executive officer, the evaluations and recommendations of the chief executive officer, and
|
|
•
|
the competitiveness of the compensation packages relative to the selected benchmarks as highlighted by the independent compensation consultant's analysis.
|
|
|
|
2013 Base Salary
|
|
% Increase
|
|
2014 Base Salary
|
|
% Increase
|
|
2015 Base Salary
|
|
Colin M. Angle
|
|
$625,000
|
|
4.0%
|
|
$650,000
|
|
3.8%
|
|
$675,000
|
|
Alison Dean
|
|
$325,000
|
|
23.1%
|
|
$400,000
|
|
7.5%
|
|
$430,000
|
|
Russell J. Campanello
|
|
$325,000
|
|
—%
|
|
$325,000
|
|
4.6%
|
|
$340,000
|
|
Christian Cerda
|
|
|
|
|
|
$350,000
|
|
14.3%
|
|
$400,000
|
|
Paolo Pirjanian
|
|
$325,000
|
|
7.7%
|
|
$350,000
|
|
7.1%
|
|
$375,000
|
|
|
Incentive Bonus Award Opportunity Payout Scale (% of base salary)
|
||||
|
|
Threshold
(25% of target opportunity) (1)
|
|
Target (100%)
|
|
Maximum
(195% of target opportunity) (2)
|
|
Colin M. Angle
|
25.00%
|
|
100%
|
|
195.00%
|
|
Alison Dean
|
15.63%
|
|
62.5%
|
|
121.88%
|
|
Russell J. Campanello
|
15.00%
|
|
60%
|
|
117.00%
|
|
Christian Cerda
|
12.50%
|
|
50%
|
|
97.50%
|
|
Paolo Pirjanian
|
15.00%
|
|
60%
|
|
117.00%
|
|
(1)
|
Cash incentive payments are made only after the Company has achieved specified Adjusted EBITDA, excluding cash incentive compensation expense.
|
|
(2)
|
This reflects the maximum incentive cash payout levels established under our Senior Executive Incentive Compensation Plan for 2014 based on the specific targets established for fiscal 2014.
|
|
Performance Measure
|
|
Weighting
|
|
Performance Goal
|
||||
|
|
Threshold
|
|
Target
|
|
Maximum
|
|||
|
Adjusted EBITDA, excluding cash incentive compensation expense
|
|
50%
|
|
$81.6 million
|
|
$90.7 million
|
|
$117.9 million
|
|
Revenue
|
|
50%
|
|
$518.0 million
|
|
$575.5 million
|
|
$748.2 million
|
|
Performance Measure
|
|
Weighting
|
|
Performance Goal
|
||||
|
|
Threshold
|
|
Target
|
|
Maximum
|
|||
|
Adjusted EBITDA, excluding cash incentive compensation expense
|
|
37.5%
|
|
$81.6 million
|
|
$90.7 million
|
|
$117.9 million
|
|
Home Robots Business Unit Revenue
|
|
62.5%
|
|
$462.6 million
|
|
$514.0 million
|
|
$668.2 million
|
|
|
|
Performance Goal
|
|
|
|
|
||||
|
Metric
|
|
Threshold
|
|
Target
(100%)
|
|
Maximum
|
|
2014 Actual
Performance
|
|
Actual
Percentage
Earned (as %
of target)
|
|
|
|
$ in millions
|
|
|
||||||
|
Adjusted EBITDA, excluding cash incentive compensation expense
|
|
$81.6
|
|
$90.7
|
|
$117.9
|
|
$88.2
|
|
86%
|
|
Company Revenue
|
|
$518.0
|
|
$575.5
|
|
$748.2
|
|
$556.8
|
|
84%
|
|
Home Robots Revenue
|
|
$462.6
|
|
$514.0
|
|
$668.2
|
|
$507.4
|
|
94%
|
|
|
|
Incentive Bonus Award
|
||||
|
Original Target Incentive
Opportunity
|
|
Achievement
|
|
ICP Earned & Paid
|
||
|
Colin M. Angle
|
|
$650,000
|
|
85%
|
|
$552,500
|
|
Alison Dean
|
|
$250,000
|
|
85%
|
|
$212,500
|
|
Russell J. Campanello
|
|
$195,000
|
|
85%
|
|
$165,750
|
|
Christian Cerda
|
|
$175,000
|
|
91%
|
|
$159,250
|
|
Paolo Pirjanian
|
|
$210,000
|
|
85%
|
|
$178,500
|
|
•
|
Alignment with business strategy;
|
|
•
|
Alignment with stockholder interest in improving long-term business fundamentals;
|
|
•
|
Correlation with total stockholder return; and
|
|
•
|
Complementary to our short-term incentive metrics.
|
|
2014 - 2016
PSU Performance Cycle
|
|
Operating Income Percent
|
||||||||
|
Threshold
|
|
Target
|
|
Maximum
|
|
Actual Performance Achieved
|
|
Actual Payout Level Achieved
|
||
|
2014
|
|
8.0%
|
|
8.0%
|
|
8.0%
|
|
9.5%
|
|
100%
|
|
2015
|
|
9.0%
|
|
9.0%
|
|
9.0%
|
|
—%
|
|
—%
|
|
2016
|
|
10.0%
|
|
10.0%
|
|
10.0%
|
|
—%
|
|
—%
|
|
Cumulative
|
|
9.1%
|
|
9.1%
|
|
9.1%
|
|
—%
|
|
—%
|
|
|
|
2014-2016 PSUs Granted & Earned
|
||||||||
|
|
|
PSUs Granted
|
|
2014 Earned PSUs (1)
|
|
2015 Earned PSUs (1)
|
|
2016 Earned PSUs
|
|
Total PSUs Earned to Date
|
|
Colin M. Angle
|
|
13,550
|
|
4,516
|
|
—
|
|
—
|
|
4,516
|
|
Alison Dean
|
|
4,467
|
|
1,489
|
|
—
|
|
—
|
|
1,489
|
|
Russell J. Campanello
|
|
4,308
|
|
1,436
|
|
—
|
|
—
|
|
1,436
|
|
Paolo Pirjanian
|
|
4,925
|
|
1,641
|
|
—
|
|
—
|
|
1,641
|
|
•
|
Our compensation program for executive officers is designed to provide a balanced mix of cash and equity and annual and longer-term incentives, including compensation based on the achievement of performance targets.
|
|
•
|
The base salary portion of compensation is designed to provide a steady income regardless of our stock price performance so executives do not feel pressured to focus primarily on stock price performance to the detriment of other important business metrics.
|
|
•
|
Our stock option grants and restricted stock unit grants generally vest over four years and, in the case of stock options, are only valuable if our stock price increases over time.
|
|
•
|
Our performance share units vest only after the achievement of significant long-term metrics designed to drive the long-term interests of our stockholders.
|
|
•
|
Performance share unit awards align the interests of our executive officers with the success of our business strategy.
|
|
•
|
Maximum payout levels for cash incentive compensation are capped.
|
|
•
|
Our stock ownership guidelines align the interests of our executive officers with those of our stockholders.
|
|
•
|
PM&P did not provide any services to us or our management other than service to the compensation committee (including compensation benchmarking for our senior leadership team), and it its services were limited to executive compensation consulting.
|
|
•
|
Fees paid by us to PM&P represented 0.1% of PM&P's total revenue for the period December 2013 through December 2014;
|
|
•
|
PM&P maintains a Conflicts Policy and an Insider Trading Policy which were provided to the compensation committee with specific policies and procedures designed to ensure independence;
|
|
•
|
None of the PM&P consultants on our account had any business or personal relationship with our compensation committee members;
|
|
•
|
None of the PM&P consultants on our account, or PM&P, had any business or personal relationship with our executive officers; and
|
|
•
|
None of the PM&P consultants on our account directly own shares of our stock.
|
|
Name and Principal Position
|
|
Year
|
|
Salary ($)(1)
|
|
Bonus
($) |
|
Stock
Awards ($)(2) |
|
Option
Awards ($)(2) |
|
Non-Equity Incentive Plan Compensation
($)(3) |
|
All Other Compensation
($)(4) |
|
Total
($)
|
|||||||
|
Colin M. Angle
|
|
2014
|
|
646,154
|
|
|
—
|
|
|
1,762,178
|
|
|
589,970
|
|
|
552,500
|
|
|
7,800
|
|
|
3,558,602
|
|
|
Chairman, Chief Executive Officer and Director
|
|
2013
|
|
613,462
|
|
|
—
|
|
|
1,514,475
|
|
|
379,237
|
|
|
981,250
|
|
|
7,650
|
|
|
3,496,074
|
|
|
|
2012
|
|
525,000
|
|
|
105,000
|
|
|
2,160,438
|
|
|
535,742
|
|
|
—
|
|
|
7,500
|
|
|
3,333,680
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Alison Dean
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Executive Vice President, Chief Financial Officer, Treasurer and Principal Accounting Officer
|
|
2014
|
|
388,462
|
|
|
—
|
|
|
580,890
|
|
|
194,546
|
|
|
212,500
|
|
|
7,800
|
|
|
1,384,198
|
|
|
|
2013
|
|
308,838
|
|
|
—
|
|
|
721,142
|
|
|
179,783
|
|
|
306,150
|
|
|
7,650
|
|
|
1,523,563
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Russell J. Campanello
|
|
2014
|
|
325,000
|
|
|
—
|
|
|
560,299
|
|
|
187,841
|
|
|
165,750
|
|
|
7,800
|
|
|
1,246,690
|
|
|
Executive Vice President, Human Resources and Corporate Communications
|
|
2013
|
|
322,115
|
|
|
—
|
|
|
270,319
|
|
|
67,618
|
|
|
306,150
|
|
|
7,650
|
|
|
973,852
|
|
|
|
2012
|
|
300,000
|
|
|
82,000
|
|
|
557,060
|
|
|
72,176
|
|
|
—
|
|
|
7,500
|
|
|
1,018,736
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Christian Cerda
|
|
2014
|
|
335,385
|
|
|
|
|
360,889
|
|
|
120,563
|
|
|
159,250
|
|
|
7,800
|
|
|
983,887
|
|
|
|
Executive Vice President and General Manager, Home Robots Business Unit
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Paolo Pirjanian
|
|
2014
|
|
346,154
|
|
|
—
|
|
|
640,496
|
|
|
214,660
|
|
|
178,500
|
|
|
7,800
|
|
|
1,387,610
|
|
|
Executive Vice President, Chief Technology Officer
|
|
2013
|
|
319,606
|
|
|
—
|
|
|
270,319
|
|
|
67,618
|
|
|
306,150
|
|
|
7,650
|
|
|
971,343
|
|
|
(1)
|
Represents salary earned in the fiscal years presented, which covered 52 weeks for fiscal years 2014, 2013 and 2012.
|
|
(2)
|
Represents the aggregate grant date fair value for stock and option awards granted in the fiscal years ended
December 27, 2014
, December 28, 2013 and December 29, 2012, as appropriate, in accordance with FASB ASC Topic 718. See the information appearing in note 9 to our consolidated financial statements included as part of our Annual Report on Form 10-K for the fiscal year ended
December 27, 2014
for certain assumptions made in the valuation of stock and option awards.
|
|
(3)
|
Represents amounts paid in 2014 under the Company's Senior Executive Incentive Compensation Plan for performance in the fiscal year ended
December 27, 2014
.
|
|
(4)
|
Includes 401(k) matching contributions for each of our named executive officers. Excludes medical, group life insurance and certain other benefits received by the named executive officers that are available generally to all of our salaried employees and certain perquisites and other personal benefits received by the named executive officers which do not exceed $10,000 in the aggregate.
|
|
|
|
|
|
Estimated Future Payouts Under
Non-Equity Incentive Plan Awards(1) |
|
Estimated Future Payouts Under
Equity Incentive Plan Awards(2) |
|
All Other
Stock
Awards:
Number
of Shares of Stock or Units (#)(3) |
|
All Other
Option
Awards:
Number of
Securities Underlying Options (#)(3) |
|
Exercise
or Base Price of Option Awards ($/Sh) |
|
Grant
Date Fair Value of Stock and Option Awards ($) |
|||||||||||||||||||
|
Name
|
|
Grant
Date
|
|
Threshold
($) |
|
Target
($) |
|
Maximum
($) |
|
Threshold
($) |
|
Target
($) |
|
Maximum
($) |
|
||||||||||||||||||
|
Colin M. Angle
|
|
—
|
|
|
162,500
|
|
|
650,000
|
|
|
1,267,500
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
3/7/2014
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
587,393
|
|
|
587,393
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
3/7/2014
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
27,100
|
|
|
—
|
|
|
—
|
|
|
1,174,785
|
|
|
|
|
3/7/2014
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
15,475
|
|
|
43.35
|
|
|
297,445
|
|
|
|
|
6/6/2014
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
19,700
|
|
|
35.43
|
|
|
292,525
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Alison Dean
|
|
—
|
|
|
62,500
|
|
|
250,000
|
|
|
487,500
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
3/7/2014
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
193,644
|
|
|
193,644
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
3/7/2014
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
8,933
|
|
|
—
|
|
|
—
|
|
|
387,246
|
|
|
|
|
3/7/2014
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
5,100
|
|
|
43.35
|
|
|
98,027
|
|
|
|
|
6/6/2014
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
6,500
|
|
|
35.43
|
|
|
96,519
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Russell J. Campanello
|
|
—
|
|
|
48,750
|
|
|
195,000
|
|
|
380,250
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
3/7/2014
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
186,752
|
|
|
186,752
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
3/7/2014
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
8,617
|
|
|
—
|
|
|
—
|
|
|
373,547
|
|
|
|
|
3/7/2014
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
4,925
|
|
|
43.35
|
|
|
94,663
|
|
|
|
|
6/6/2014
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
6,275
|
|
|
35.43
|
|
|
93,177
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Christian D. Cerda
|
|
—
|
|
|
43,750
|
|
|
175,000
|
|
|
341,250
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
3/7/2014
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
8,325
|
|
|
—
|
|
|
—
|
|
|
360,889
|
|
|
|
|
3/7/2014
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
3,163
|
|
|
43.35
|
|
|
60,796
|
|
|
|
|
6/6/2014
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
4,025
|
|
|
35.43
|
|
|
59,767
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Paolo Pirjanian
|
|
—
|
|
|
52,500
|
|
|
210,000
|
|
|
409,500
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
3/7/2014
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
213,499
|
|
|
213,499
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
3/7/2014
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
9,850
|
|
|
—
|
|
|
—
|
|
|
426,998
|
|
|
|
|
3/7/2014
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
5,625
|
|
|
43.35
|
|
|
108,118
|
|
|
|
|
6/6/2014
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
7,175
|
|
|
35.43
|
|
|
106,542
|
|
|
(1)
|
This reflects the threshold, target and maximum incentive cash payout levels established under our Senior Executive Incentive Compensation Plan. The actual amounts paid for fiscal year 2014 are disclosed in the "Non-Equity Incentive Plan Compensation" column of the Summary Compensation Table.
|
|
(2)
|
This reflects the threshold, target and maximum equity incentive payout levels associated with performance share units made pursuant to our 2005 Stock Option and Incentive Plan, as amended (the “2005 Plan”), which amounts will be payable in shares of our common stock, if the performance thresholds are met under the terms of the awards
|
|
(3)
|
All stock awards and option awards were made pursuant to the 2005 Plan.
|
|
|
|
Option Awards
|
|
Stock Awards
|
|||||||||||||||||||||
|
Name
|
|
Grant
Date
|
|
Number of
Securities Underlying Unexercised Options (#) Exercisable |
|
Number of
Securities Underlying Unexercised Options (#) Unexercisable(1) |
|
Option
Exercise Price ($) |
|
Option
Expiration Date |
|
Number of
Shares or Units of Stock That Have Not Vested (#)(2) |
|
Market Value of
Shares or Units of Stock That Have Not Vested ($)(3) |
|
Equity Incentive Plan Awards; Number of Unearned Shares, Units or Other Rights That Have Not Vested (#)(4)
|
|
Equity Incentive Plan Awards; Payout or Market Value of Unearned Shares, Units or Other Rights That Have Not Vested ($)(3)
|
|||||||
|
Colin M. Angle
|
|
2/20/2009
|
|
73,829
|
|
|
—
|
|
|
7.76
|
|
|
2/20/2016
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
4/2/2010
|
|
113,950
|
|
|
—
|
|
|
14.52
|
|
|
4/2/2017
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
4/1/2011
|
|
39,550
|
|
|
5,650
|
|
|
33.48
|
|
|
4/1/2018
|
|
5,700
|
|
|
198,417
|
|
|
—
|
|
|
—
|
|
|
|
|
3/9/2012
|
|
28,068
|
|
|
12,757
|
|
|
26.59
|
|
|
3/9/2019
|
|
40,624
|
|
|
1,414,121
|
|
|
—
|
|
|
—
|
|
|
|
|
3/8/2013
|
|
15,827
|
|
|
20,348
|
|
|
22.86
|
|
|
3/8/2020
|
|
49,687
|
|
|
1,729,604
|
|
|
—
|
|
|
—
|
|
|
|
|
3/7/2014
|
|
—
|
|
|
15,475
|
|
|
43.35
|
|
|
3/7/2021
|
|
27,100
|
|
|
943,351
|
|
|
13,550
|
|
|
471,676
|
|
|
|
|
6/6/2014
|
|
—
|
|
|
19,700
|
|
|
35.43
|
|
|
6/6/2021
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Alison Dean
|
|
7/25/2008
|
|
1,873
|
|
|
—
|
|
|
14.09
|
|
|
7/25/2015
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
4/2/2010
|
|
11,000
|
|
|
—
|
|
|
14.52
|
|
|
4/2/2017
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
4/1/2011
|
|
6,454
|
|
|
921
|
|
|
33.48
|
|
|
4/1/2018
|
|
931
|
|
|
32,408
|
|
|
—
|
|
|
—
|
|
|
|
|
3/9/2012
|
|
3,249
|
|
|
1,476
|
|
|
26.59
|
|
|
3/9/2019
|
|
4,700
|
|
|
163,607
|
|
|
—
|
|
|
—
|
|
|
|
|
3/8/2013
|
|
2,177
|
|
|
2,798
|
|
|
22.86
|
|
|
3/8/2020
|
|
6,825
|
|
|
237,578
|
|
|
—
|
|
|
—
|
|
|
|
|
6/7/2013
|
|
3,179
|
|
|
5,296
|
|
|
34.67
|
|
|
6/7/2020
|
|
11,100
|
|
|
386,391
|
|
|
—
|
|
|
—
|
|
|
|
|
3/7/2014
|
|
—
|
|
|
5,100
|
|
|
43.35
|
|
|
3/7/2021
|
|
8,933
|
|
|
310,958
|
|
|
4,467
|
|
|
155,496
|
|
|
|
|
6/6/2014
|
|
—
|
|
|
6,500
|
|
|
35.43
|
|
|
6/6/2021
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Russell J. Campanello
|
|
12/30/2010
|
|
33,750
|
|
|
6,250
|
|
|
24.53
|
|
|
12/30/2017
|
|
8,750
|
|
|
304,588
|
|
|
—
|
|
|
—
|
|
|
|
|
3/9/2012
|
|
3,781
|
|
|
1,719
|
|
|
26.59
|
|
|
3/9/2019
|
|
10,474
|
|
|
364,600
|
|
|
—
|
|
|
—
|
|
|
|
|
3/8/2013
|
|
2,823
|
|
|
3,627
|
|
|
22.86
|
|
|
3/8/2020
|
|
8,868
|
|
|
308,695
|
|
|
—
|
|
|
—
|
|
|
|
|
3/7/2014
|
|
—
|
|
|
4,925
|
|
|
43.35
|
|
|
3/7/2021
|
|
8,617
|
|
|
299,958
|
|
|
4,308
|
|
|
149,961
|
|
|
|
|
6/6/2014
|
|
—
|
|
|
6,275
|
|
|
35.43
|
|
|
6/6/2021
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Christian D. Cerda
|
|
3/8/2013
|
|
26,250
|
|
|
33,750
|
|
|
22.86
|
|
|
3/8/2020
|
|
22,500
|
|
|
783,225
|
|
|
—
|
|
|
—
|
|
|
|
|
3/7/2014
|
|
—
|
|
|
3,163
|
|
|
43.35
|
|
|
3/7/2021
|
|
8,325
|
|
|
289,793
|
|
|
—
|
|
|
—
|
|
|
|
|
6/6/2014
|
|
—
|
|
|
4,025
|
|
|
35.43
|
|
|
6/6/2021
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Paolo Pirjanian
|
|
10/1/2012
|
(5)
|
16,751
|
|
|
10,548
|
|
|
4.81
|
|
|
6/11/2022
|
|
—
|
|
|
—
|
|
|
|
|
|
||
|
|
|
10/1/2012
|
(5)
|
3,834
|
|
|
—
|
|
|
3.54
|
|
|
5/6/2021
|
|
—
|
|
|
—
|
|
|
|
|
|
||
|
|
|
12/7/2012
|
|
29,500
|
|
|
50,000
|
|
|
18.47
|
|
|
12/7/2019
|
|
15,000
|
|
|
522,150
|
|
|
|
|
|
||
|
|
|
3/8/2013
|
|
2,017
|
|
|
3,627
|
|
|
22.86
|
|
|
3/8/2020
|
|
8,868
|
|
|
308,695
|
|
|
|
|
|
||
|
|
|
3/7/2014
|
|
—
|
|
|
5,625
|
|
|
43.35
|
|
|
3/7/2021
|
|
9,850
|
|
|
342,879
|
|
|
4,925
|
|
|
171,439
|
|
|
|
|
6/6/2014
|
|
—
|
|
|
7,175
|
|
|
35.43
|
|
|
6/6/2021
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(1)
|
Stock option grants vest over a four-year period, at a rate of twenty-five percent (25%) on the first anniversary of the grant, and the remainder in equal quarterly installments thereafter.
|
|
(2)
|
Restricted stock unit awards vest over a four-year period, at a rate of twenty-five percent (25%) on each anniversary of the grant.
|
|
(3)
|
Amounts disclosed in this column were calculated based on the fair market value of our common stock as of
December 27, 2014
.
|
|
(4)
|
Performance stock unit awards are earned over a three-year period and vest at the end of such three-year period, dependent on achievement of pre-established performance goals and objectives. For additional information on the performance stock unit awards see the section above entitled “ Compensation Discussion and Analysis - Elements of Compensation - Long-Term Incentives.”
|
|
(5)
|
The stock options granted to Dr. Pirjanian on October 1, 2012 were granted as replacement awards for unvested stock options that Dr. Pirjanian held in Evolution Robotics, Inc. as of the date that the Company acquired Evolution Robotics, Inc.
|
|
|
|
Option Awards
|
|
Stock Awards
|
||||||
|
Name
|
|
Shares
Acquired on Exercise(#) |
|
Value
Realized on Exercise($)(1) |
|
Number of Shares
Acquired on Vesting(#) |
|
Value
Realized on Vesting($)(2) |
||
|
Colin M. Angle
|
|
47,333
|
|
|
1,032,279
|
|
|
50,138
|
|
2,157,317
|
|
Alison Dean
|
|
18,970
|
|
|
481,229
|
|
|
9,981
|
|
406,909
|
|
Russell J. Campanello
|
|
20,000
|
|
|
259,400
|
|
|
16,945
|
|
664,342
|
|
Christian D. Cerda
|
|
—
|
|
|
—
|
|
|
7,500
|
|
324,600
|
|
Paolo Pirjanian
|
|
21,306
|
|
|
484,123
|
|
|
10,457
|
|
392,054
|
|
(1)
|
Amounts disclosed in this column were calculated based on the difference between the fair market value of our common stock on the date of exercise and the exercise price of the options in accordance with regulations promulgated under the Exchange Act.
|
|
(2)
|
Amounts disclosed in this column were calculated based on the fair market value of the shares on the date of settlement upon vesting.
|
|
Name
|
|
Base
Salary ($) |
|
Continuation of
Health Plan Premium Payments ($) |
|
Total ($)
|
|
Colin Angle
|
|
325,000
|
|
10,023
|
|
335,023
|
|
Alison Dean
|
|
200,000
|
|
8,947
|
|
208,947
|
|
Russ Campanello
|
|
162,500
|
|
10,023
|
|
172,523
|
|
Christian Cerda
|
|
175,000
|
|
10,023
|
|
185,023
|
|
Paolo Pirjanian
|
|
175,000
|
|
10,023
|
|
185,023
|
|
Name
|
|
Base
Salary ($) |
|
Bonus
($) |
|
Continuation
of Health Plan Premium Payments ($) |
|
Market
Value of Stock Options ($) |
|
Market
Value of Restricted Stock and Restricted Stock Units ($) |
|
Total
($) |
||||||
|
Colin Angle
|
|
1,300,000
|
|
|
1,300,000
|
|
|
40,090
|
|
|
355,536
|
|
|
4,442,696
|
|
|
7,438,322
|
|
|
Alison Dean
|
|
800,000
|
|
|
500,000
|
|
|
35,789
|
|
|
47,535
|
|
|
1,182,774
|
|
|
2,566,098
|
|
|
Russ Campanello
|
|
650,000
|
|
|
390,000
|
|
|
40,090
|
|
|
121,723
|
|
|
1,327,827
|
|
|
2,529,640
|
|
|
Christian Cerda
|
|
700,000
|
|
|
350,000
|
|
|
40,090
|
|
|
403,313
|
|
|
1,073,018
|
|
|
2,566,421
|
|
|
Paolo Pirjanian
|
|
700,000
|
|
|
420,000
|
|
|
40,090
|
|
|
1,176,783
|
|
|
1,230,847
|
|
|
3,567,720
|
|
|
|
|
|
Annual retainer for Board membership
|
$35,000
|
|
Annual retainer for lead independent director
|
$7,000
|
|
Audit Committee
|
|
|
Annual retainer for committee membership
|
$10,000
|
|
Additional retainer for committee chair
|
$10,000
|
|
Compensation Committee
|
|
|
Annual retainer for committee membership
|
$7,500
|
|
Additional retainer for committee chair
|
$7,500
|
|
Nominating and Corporate Governance Committee
|
|
|
Annual retainer for committee membership
|
$5,000
|
|
Additional retainer for committee chair
|
$5,000
|
|
Name
|
|
Fees Earned or
Paid in Cash ($) |
|
Stock Awards
($)(3) |
|
Total ($)
|
|||
|
Ronald Chwang, Ph.D.
|
|
46,250
|
|
|
114,899
|
|
|
161,149
|
|
|
Gail Deegan
|
|
48,750
|
|
|
114,899
|
|
|
163,649
|
|
|
Deborah G. Ellinger
|
|
46,250
|
|
|
114,899
|
|
|
161,149
|
|
|
Jacques S. Gansler, Ph.D. (1)
|
|
20,000
|
|
|
—
|
|
|
20,000
|
|
|
Andrea Geisser
|
|
58,750
|
|
|
114,899
|
|
|
173,649
|
|
|
Paul J. Kern, Gen. U.S. Army (ret.)
|
|
48,750
|
|
|
114,899
|
|
|
163,649
|
|
|
George C. McNamee
|
|
66,500
|
|
|
114,899
|
|
|
181,399
|
|
|
Paul L. Sagan (2)
|
|
48,750
|
|
|
114,899
|
|
|
163,649
|
|
|
Michelle V. Stacy
|
|
21,250
|
|
|
219,980
|
|
|
241,230
|
|
|
(1)
|
Mr. Gansler did not stand for re-election at the 2014 annual meeting of stockholders.
|
|
(2)
|
Mr. Sagan deferred all of his 2014 cash compensation pursuant to our Non-employee Directors’ Deferred Compensation Program under which he received stock units in lieu of cash.
|
|
(3)
|
Represents the grant date fair value of restricted stock units awarded in the fiscal year ended
December 27, 2014
in accordance with FASB ASC Topic 718. The grant date fair value is the fair market value of our common stock on the date of grant multiplied by the number of shares of common stock underlying such restricted stock unit award.
|
|
Name
|
|
Number of
Securities Underlying Unexercised Options |
|
Number of
Unvested Restricted Stock Units |
||
|
Ronald Chwang, Ph.D.
|
|
30,000
|
|
|
3,243
|
|
|
Gail Deegan
|
|
—
|
|
|
4,772
|
|
|
Deborah G. Ellinger
|
|
—
|
|
|
6,927
|
|
|
Andrea Geisser
|
|
40,000
|
|
|
3,243
|
|
|
Paul J. Kern, Gen. U.S. Army (ret.)
|
|
60,000
|
|
|
3,243
|
|
|
George C. McNamee
|
|
70,000
|
|
|
3,243
|
|
|
Paul L. Sagan
|
|
2,500
|
|
|
3,243
|
|
|
Michelle V. Stacy
|
|
—
|
|
|
6,608
|
|
|
|
|
2014
|
|
2013
|
||||
|
Audit Fees
|
|
$
|
963,497
|
|
|
$
|
895,013
|
|
|
Audit-Related Fees
|
|
124,569
|
|
|
38,499
|
|
||
|
Tax Fees
|
|
150,000
|
|
|
6,900
|
|
||
|
All Other Fees
|
|
3,394
|
|
|
3,394
|
|
||
|
Total
|
|
$
|
1,241,460
|
|
|
$
|
943,806
|
|
|
|
|
|
|
|
||||
|
•
|
The maximum number of shares of common stock available for awards under the 2015 Plan is 3,100,000 shares;
|
|
•
|
The award of stock options (both incentive and non-qualified options), stock appreciation rights, restricted stock, restricted stock units, unrestricted stock, performance shares, dividend equivalent rights and cash-based awards is permitted;
|
|
•
|
Grants of “full-value” awards are deemed for purposes of determining the number of shares available for future grants under the 2015 Plan as an award for 1.61 shares for each share of common stock subject to the award. Grants of stock options or stock appreciation rights are deemed to be an award of one share for each share of common stock subject to the award;
|
|
•
|
Shares tendered or held back for taxes or to pay the exercise price with respect to an award will not be added back to the reserved pool under the 2015 Plan. Upon the exercise of a stock appreciation right that is settled in shares of common stock, the full number of shares underlying the award will be charged to the reserved pool. Additionally, shares we reacquire on the open market will not be added to the reserved pool;
|
|
•
|
Stock options and stock appreciation rights will not be repriced in any manner without stockholder approval;
|
|
•
|
Minimum vesting periods are required for stock options, stock appreciation rights, restricted stock, restricted stock units and performance share awards;
|
|
•
|
No more than 2,000,000 shares subject to awards may be awarded to our non-employee directors in any calendar year period, no more than 2,500,000 shares subject to stock options or stock appreciation rights may be granted to any individual grantee in any calendar year period, and no more than 5% of the shares reserved may be granted under the 2015 plan as unrestricted stock awards;
|
|
•
|
Any material amendment to the 2015 Plan is subject to approval by our stockholders; and
|
|
•
|
The term of the 2015 Plan will expire on May 20, 2025, ten years from the date of the 2015 annual meeting.
|
|
|
|
Options
|
|
Awards
|
|||||||||
|
Name and Principal Position
|
|
Average Exercise Price ($)
|
|
Number of Awards (#)
|
|
Dollar Value ($)(1)
|
|
Number of Awards (#)
|
|||||
|
Colin M. Angle, Chairman, Chief Executive Officer and Director
|
|
$
|
38.91
|
|
|
35,175
|
|
|
1,762,178
|
|
|
40,650
|
|
|
Alison Dean, Executive Vice President, Chief Financial Officer, Treasurer and Principal Accounting Officer
|
|
$
|
38.91
|
|
|
11,600
|
|
|
580,890
|
|
|
13,400
|
|
|
Russell J. Campanello, Executive Vice President, Human Resources and Corporate Communications
|
|
$
|
38.91
|
|
|
11,200
|
|
|
560,299
|
|
|
12,925
|
|
|
Christian Cerda, Executive Vice President and General Manager, Home Business Unit
|
|
$
|
38.91
|
|
|
7,188
|
|
|
360,889
|
|
|
8,325
|
|
|
Paolo Pirjanian, Executive Vice President and Chief Technology Officer
|
|
$
|
38.91
|
|
|
12,800
|
|
|
640,497
|
|
|
14,775
|
|
|
All executive officers, as a group
|
|
$
|
38.91
|
|
(2)
|
90,763
|
|
|
4,225,541
|
|
(3)
|
97,475
|
|
|
All current directors who are not executive officers, as a group
|
|
—
|
|
(2)
|
—
|
|
|
1,024,277
|
|
(3)
|
29,309
|
|
|
|
All current employees who are not executive officers or directors, as a group
|
|
$
|
35.94
|
|
(2)
|
142,418
|
|
|
8,985,843
|
|
(3)
|
245,375
|
|
|
(1)
|
The valuation of stock awards is based on the grant date fair value computed in accordance with FASB ASC Topic 718. The assumptions used to calculate the value of stock awards are set forth in the footnotes to our consolidated financial statements included in our Annual Report on Form 10-K for the fiscal year ended December 27, 2014.
|
|
(2)
|
Represents the weighted-average exercise price for the group.
|
|
(3)
|
Represents the total grant date fair value for the group.
|
|
Plan category
|
|
Number of securities to be issued upon exercise of outstanding options, warrants and rights (a)
|
|
Weighted Average exercise price of outstanding options, warrants and rights (b)
|
|
Number of securities remaining available for future issuance under equity compensation plan (excluding securities referenced in column (a))(c)
|
|
|||||||
|
Equity compensation plans approved by security holders
|
|
2,315,449
|
|
(1
|
)
|
$
|
23.77
|
|
(2
|
)
|
4,762,446
|
|
(3
|
)
|
|
Equity compensation plans not approved by security holders
|
|
67,726
|
|
(4
|
)
|
$
|
4.53
|
|
|
—
|
|
|
||
|
Total
|
|
2,383,175
|
|
(5
|
)
|
$
|
22.89
|
|
|
4,762,446
|
|
|
||
|
(1)
|
Includes 1,405,594 shares of common stock issuable upon the exercise of outstanding options, 880,138 shares of common stock issuable upon the vesting of restricted stock units, and 29,717 shares of common stock issuable upon the vesting of performance shares if specified performance metrics are achieved.
|
|
(2)
|
Since restricted stock units do not have any exercise price, such units are not included in the weighted average exercise price calculation.
|
|
(3)
|
As of April 9, 2015, there were zero shares available for grants under the Amended and Restated 2004 Stock Option and Incentive Plan, 3,750,843 shares available for grants under our 2005 Stock Option and Incentive Plan, as amended, and zero shares available under the
Evolution Robotics, Inc. 2007 Stock Plan. If the 2015 Plan is approved, no further shares may be granted under any previous Plans.
|
|
(4)
|
Represents shares issued pursuant to the Evolution Robotics, Inc. 2007 Stock Plan, acquired by the company as part of the acquisition of Evolution Robotics, Inc., on October 1, 2012.
|
|
(5)
|
Includes 1,473,320 shares of common stock issuable upon the exercise of outstanding options.
|
|
|
|
For the twelve months ended
|
||||||
|
|
|
December 27,
2014 |
|
December 28,
2013 |
||||
|
Net income
|
|
$
|
37,803
|
|
|
$
|
27,641
|
|
|
Interest income, net
|
|
(673)
|
|
|
(660)
|
|
||
|
Income tax expense
|
|
14,606
|
|
|
4,774
|
|
||
|
Depreciation
|
|
9,192
|
|
|
8,077
|
|
||
|
Amortization
|
|
3,857
|
|
|
4,092
|
|
||
|
EBITDA
|
|
64,785
|
|
|
43,924
|
|
||
|
Stock-based compensation expense
|
|
13,778
|
|
|
13,409
|
|
||
|
Merger and acquisition expense
|
|
—
|
|
|
400
|
|
||
|
Net intellectual property litigation expense
|
|
1,214
|
|
|
1202
|
|
||
|
Restructuring expense
|
|
—
|
|
|
3,296
|
|
||
|
Adjusted EBITDA
|
|
$
|
79,777
|
|
|
$
|
62,231
|
|
|
|
|
|
|
|
||||
|
SECTION 1.
|
GENERAL PURPOSE OF THE PLAN; DEFINITIONS
|
|
SECTION 2.
|
ADMINISTRATION OF PLAN; ADMINISTRATOR AUTHORITY TO SELECT GRANTEES AND DETERMINE AWARDS
|
|
SECTION 3.
|
STOCK ISSUABLE UNDER THE PLAN; MERGERS; SUBSTITUTION
|
|
SECTION 4.
|
ELIGIBILITY
|
|
SECTION 5.
|
STOCK OPTIONS
|
|
SECTION 6.
|
STOCK APPRECIATION RIGHTS
|
|
SECTION 7.
|
RESTRICTED STOCK AWARDS
|
|
SECTION 8.
|
RESTRICTED STOCK UNITS
|
|
SECTION 9.
|
UNRESTRICTED STOCK AWARDS
|
|
SECTION 10.
|
CASH-BASED AWARDS
|
|
SECTION 11.
|
PERFORMANCE SHARE AWARDS
|
|
SECTION 12.
|
PERFORMANCE-BASED AWARDS TO COVERED EMPLOYEES
|
|
SECTION 13.
|
DIVIDEND EQUIVALENT RIGHTS
|
|
SECTION 14.
|
TRANSFERABILITY OF AWARDS
|
|
SECTION 15.
|
TAX WITHHOLDING
|
|
SECTION 16.
|
SECTION 409A AWARDS
|
|
SECTION 17.
|
TERMINATION OF EMPLOYMENT, TRANSFER, LEAVE OF ABSENCE, ETC.
|
|
SECTION 18.
|
AMENDMENTS AND TERMINATION
|
|
SECTION 19.
|
STATUS OF PLAN
|
|
SECTION 20.
|
GENERAL PROVISIONS
|
|
SECTION 21.
|
EFFECTIVE DATE OF PLAN
|
|
SECTION 22.
|
GOVERNING LAW
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|